Regulators in the United Kingdom have approved full marketing authorization for Gaithersburg-based Novavax’s updated, protein-based COVID-19 booster shot, but regulators in the European Union have ...

Novavax, Inc. recently announced at the Jefferies London Healthcare Conference 2025 that it is shifting its focus from direct COVID-19 commercial operations to an expanded research and development ...

Novavax says its COVID-19 vaccine appears 89% effective, based on early findings from a British study. According to USA Today, the two-dose vaccine was just 60% effective in the South African trial.

A new Covid-19 vaccine from Novavax was 89% effective and appeared to offer protection against some variants of the coronavirus in a clinical trial conducted in the UK, the American biotech firm has ...

Novavax, Inc. (NASDAQ:NVAX) ranks among the most oversold biotech stocks to invest in. Novavax, Inc. (NASDAQ:NVAX) announced ...

Novavax, Inc. stock has been facing a downward spiral, but there may be a short-term trading opportunity if FDA approval for its COVID-19 vaccine is positive. The high level of short interest in ...

Shares of Novavax gained downside momentum after the company announced that it reached agreement with B.Riley Secutiries for an at-the market offering of up to $500 million of its common stock.

Novavax released its FY22 earnings last week. The news was not good. Although the company did make product sales of $1.6bn, it made a substantial loss of >$650, after a >$1.7bn loss in the prior year.

Novavax (NVAX) closed at $86.55 in the latest trading session, marking a -0.67% move from the prior day. This change lagged the S&P 500's 0.09% gain on the day. Elsewhere, the Dow lost 0.16%, while ...

(Reuters) - U.S. drug developer Novavax Inc said on Friday the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373. The company and the UK government will collaborate for a ...

(Reuters) - U.S. drug developer Novavax Inc said on Friday the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373. The company and the UK government will collaborate for a ...